Global Assets Advisory »

Arrowhead Pharmaceuticals shares owned by Global Assets Advisory

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Global Assets Advisory from 13F filings

Historical chart of Global Assets Advisory investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Global Assets Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Global Assets Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $209k 3.1k 66.39
2024-03-31 $1.4M 40k 35.41

More positions owned by Global Assets Advisory

NVIDIA Corporation (NVDA)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core Us Aggbd Et (AGG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (SJNK)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Dimensional Intl (DXIV)

View all positions for Global Assets Advisory

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals